All In MedTech

FDA Clearance Tracker · P870076-S018

FALOPE-RING BAND CONTRACEPTIVE TUBAL OCCLUSION SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 22, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 22, 2016

Approved

Time to decision

105 days

Received Dec 8, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P870076-S018
Device name
FALOPE-RING BAND CONTRACEPTIVE TUBAL OCCLUSION SYSTEM
Applicant location
Southborough, MA
Received
Dec 8, 2015
Decided
Mar 22, 2016
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P870076

Device type

Device class
Class III
Regulation
21 CFR 884.5380

Every decision under product code KNH

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at 9600 Louisiana Avenue North, Brooklyn Park, MN 55445 for the production of the Falope Ring Band.

Source documents

Other decisions for Gyrus Acmi, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.